RhumbLine Advisers
CLOV icon

RhumbLine Advisers’s Clover Health Investments CLOV Stock Holding History

RhumbLine Advisers’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.21M Sell
513,414
-6,983
-1% -$31.3K ﹤0.01% 1843
2026
Q2 		$2.73M Buy
520,397
+39,538
+8% +$134K ﹤0.01% 1784
2026
Q1 		$846K Sell
480,859
-2,531
-0.5% -$5.49K ﹤0.01% 2283
2025
Q4 		$1.14M Sell
483,390
-87,398
-15% -$239K ﹤0.01% 2159
2025
Q3 		$1.75M Sell
570,788
-13,671
-2% -$39K ﹤0.01% 1991
2025
Q2 		$1.63M Buy
584,459
+577,374
+8,149% +$1.9M ﹤0.01% 1993
2025
Q1 		$25.4K Buy
7,085
+3,160
+81% +$12.7K ﹤0.01% 3703
2024
Q4 		$12.4K Buy
3,925
+324
+9% +$1.16K ﹤0.01% 3857
2024
Q3 		$10.2K Buy
+3,601
New +$8.24K ﹤0.01% 3888
2023
Q3 		– Sell
-17,242
Closed -$15.5K – 4319
2023
Q2 		$15.5K Sell
17,242
-462,191
-96% -$410K ﹤0.01% 3858
2023
Q1 		$405K Buy
479,433
+16,699
+4% +$18.3K ﹤0.01% 2513
2022
Q4 		$430K Buy
462,734
+11,668
+3% +$15.6K ﹤0.01% 2535
2022
Q3 		$767K Buy
451,066
+37,600
+9% +$98.5K ﹤0.01% 2286
2022
Q2 		$885K Buy
+413,466
New +$1.1M ﹤0.01% 2202

Other funds holding CLOV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

RhumbLine Advisers's CLOV Position: Q3 2026 in Review

RhumbLine Advisers reduced its Clover Health Investments (CLOV) stake by 1.3% in Q3 2026, selling an estimated $31.3K and leaving 513,414 shares worth $2.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1843.

RhumbLine Advisers first reported a position in CLOV in Q2 2022 and has held it in 14 quarters since. The position peaked at $2.73M in Q2 2026. 176 funds tracked by Wall St. Rank hold CLOV as of Q3 2026.

  • RhumbLine Advisers held 513,414 shares of Clover Health Investments worth $2.21M as of Q3 2026.
  • RhumbLine Advisers sold 6,983 Clover Health Investments shares in Q3 2026, an estimated $31.3K.
  • Clover Health Investments made up ﹤0.01% of RhumbLine Advisers's portfolio in Q3 2026, its #1843 holding.
  • RhumbLine Advisers first reported a position in Clover Health Investments in Q2 2022 and has held it in 14 quarters since.
  • RhumbLine Advisers's Clover Health Investments position peaked at $2.73M in Q2 2026.
  • 176 funds tracked by Wall St. Rank held Clover Health Investments as of Q3 2026.

Based on RhumbLine Advisers's 13F filing for Q3 2026, filed 10 Nov 2026.